Edison Investment Research - mic AG (1235) New beginning

Report

Edison Investment Research

New beginning

The latest announcement appears to end the days of mic’s broader ambitions. The new management is committed to a simple strategy of extracting value for shareholders from three distinct and specific operating businesses. Further sharp cost-cutting initiatives should help to reduce operating losses, which are believed to be around €3m in 2016. Valuation is hampered by the lack of 2016 accounts and ongoing refinancing talks.

31/08/2017 2 EN

Underlying

mic AG

Mic AG is a Germany-based early-stage investment company that supports companies from the conceptual phase. It focuses on technology companies from the fiber optics, clean tech, software, microsystems, information technology (IT) and life science sectors. Its portfolio comprises: u-GPS Optics GmbH, a developer of a technology for three-dimensional (3D) optical measurements, Flores Solar Water GmbH, which develops a low cost water treatment plant that uses solar thermal energy, ProximusDA, a software engineering company that specializes in system level design and software solutions, SmartM GmbH, which specializes in manufacturing products in the fields of optics, microsystems and IT, and BodyTel GmbH, a manufacturer and supplier of telemedicine solutions.

See profile

DE000A0KF6S5 Germany

Provider

Edison Investment Research

Edison is an investment research and advisory company, with offices in North America, Europe, the Middle East and AsiaPac. The heart of Edison is our world renowned equity research platform and deep multi-sector expertise. At Edison Investment Research, our research is widely read by international investors, advisors and stakeholders. Edison Advisors leverages our core research platform to provide differentiated services including investor relations and strategic consulting.

See profile

Other Reports on these Companies

Edison Investment Research

mic - Cleaning out

H119 has seen a respite from the drastic write-downs of financial assets of recent years (â‚¬0.3m against, for example, â‚¬3.9m in H218). Even so, mic remained mildly loss-making at the net level in the period, reducing equity at June 2019 to just â‚¬2.9m (â‚¬0.19 NAV per share). This is below 50% of total share capital, hence a statutory requirement to call a general meeting. Full 2018 results (net loss â‚¬4.9m) have also only just been reported, as correction of the companyâ€™s accounts for 2015 to 2017 was not completed until May this year. The main impact was on 2015 (net loss â‚¬35.7m vs ...

October 11, 2019 October 11, 2019 3 EN

Edison Investment Research

mic - Good for now

H118 results suggest continued progress in micâ€™s â€˜remarkable change of courseâ€™ although, in the absence of management commentary/guidance, underlying performance and immediate financial prospects are necessarily hard to judge. Gross profit was c 20% ahead of H217, while EBT was broadly maintained year-on-year after adjusting for one-off restructuring gains, which flattered the comparative. Significantly, there was also further marked reduction in liabilities (â‚¬0.5m vs â‚¬0.8m at December 2017) thanks to efficiencies. Restructuring was last reported in July to be largely completed, with...

October 10, 2018 October 10, 2018 3 EN

Edison Investment Research

mic - Fresh start

micâ€™s â€œremarkable change of courseâ€ looks to be proceeding well with greatly improved financials and a sharpened focus on three business areas with good potential. Newly reported unqualified accounts for 2017 show a return to profit which, however minimal (â‚¬0.1m at the net level), is welcome after the previous yearâ€™s substantial loss (c â‚¬30m), marked by significant write-downs. Restructuring is apparently largely completed, with management confident that its portfolio focus is â€œvery much on trackâ€. Ahead of the annual report with likely management commentary/ guidance, immediat...

August 10, 2018 August 10, 2018 3 EN

Record - AUME momentum and a sharper focus

Record’s Q424 trading update demonstrated continued growth in assets under management equivalent (AUME), which will support management fee growth into FY25. In FY24, AUME grew 17% to US$102.2bn, setting a new milestone in business scale. Net inflows for FY24 were US$6.8bn (FY23: US$9.1bn) or 8% of opening AUME. Performance fees of US$5.8m matched the record FY23 figure, and we expect this to offset the negative product mix in FY24. We have reduced our FY24e EPS by 1%, which is affected by £2.4bn in IT restructuring and impairment charges announced in March 2024. New CEO Dr Jan Witte is putting...

14h / 24m 14h / 24m 1 EN

Sean Conroy

Sean Conroy

Actinogen Medical - Funding in place through key catalysts

Actinogen announced a capital increase of up to A$8.9m on 3 May, consisting of a A$5.0m (gross) placement along with a shareholder rights offering (‘entitlement offer’) designed to raise up to A$3.9m (gross) from existing shareholders. The closing date of the rights offer is 29 May and, given that Actinogen shares are currently trading at c A$0.028, we assume full exercise of the rights offering in Q424 (Q2 CY24). The company expects that the proceeds (assuming full exercise of the rights offering) will extend its operating runway beyond the interim results release of the first 100 patients of...

May 15, 2024 May 15, 2024 1 EN

Pedro Fonseca

Pedro Fonseca

Henderson Opportunities Trust - A differentiated exposure to smaller companies

With a focus on long-term growth, Henderson Opportunities Trust (HOT) seeks investment opportunities across the breadth of the UK market. This includes a strong bias towards smaller and earlier-stage companies with significant potential to become tomorrow’s leading British businesses. There are tentative signs that the significant three-year underperformance of these smaller companies, and of HOT, may be coming to an end. If so, the trust is well placed to benefit and its differentiated, truly all-market approach is one that many investors would struggle to replicate. Moreover, HOT’s size and ...

May 15, 2024 May 15, 2024 1 EN

Sign-up for free to access full reports immediately

Email Address*

Choose Password* ( 6 or more characters )

Due to regulatory restrictions regarding the distribution of financial research, this report is restricted to a specific region or investor type. Get access to exclusive reports by answering the questions below.

Select your country*

Get financial insights straight to your inbox

By clicking "register" you accept the Terms and Conditions & Privacy Policy

Already on ResearchPool?

Almost there...

Are you a professional investor?

Select your country

REGISTER

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

In order to access this report please create an account.

LOGIN

New beginning

mic - Cleaning out

mic - Good for now

mic - Fresh start

Record - AUME momentum and a sharper focus

Actinogen Medical - Funding in place through key catalysts

Henderson Opportunities Trust - A differentiated exposure to smaller companies

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

Sign-up for free to access full reports immediately

ResearchPool Subscriptions

Get the most out of your insights

Why subscribe?

How to subscribe

ResearchPool Subscriptions

This report is only available to subscribers

Why subscribe?

How to subscribe